The Potential Clinical Advantages of Charged Particle Radiotherapy using Protons or Light Ions

Clinical Oncology

Volumn 20, Issue 7, 2008, Pages 555-563

  Jones, B ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Carbon ions; charged particle therapy; physics; protons; radiotherapy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; BLADDER CANCER; BRACHYTHERAPY; BRAIN CANCER; BREAST CANCER; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; COLORECTAL CANCER; COMPUTER ASSISTED RADIOTHERAPY; CONTINUING EDUCATION; ESOPHAGUS CANCER; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; LIVER CANCER; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SPECIALIST; MEGAVOLTAGE RADIOTHERAPY; METASTASIS POTENTIAL; MYELITIS; OUTCOME ASSESSMENT; PANCREAS CANCER; PARTICLE RADIATION; PATIENT COUNSELING; PHYSICIAN ATTITUDE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PNEUMONIA; RETROPERITONEAL CANCER; SARCOMA; SPINAL CORD CANCER; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; UNITED KINGDOM; URETER CANCER;

EID: 48349088947     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.02.012     Document Type: Note

References (39)

1. Maher E.J., and Makin W. Life after cancer treatment - a spectrum of chronic survivorship conditions. Clin Oncol 19 (2007) 743-745
2. Vicary P., Johnson M., Maher J., and Macmillan Late Effects Project Group. To my oncologist - an open letter from a patient at the end of follow-up. Clin Oncol 19 (2007) 746-747
3. Andreyev H.J.N. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol 19 (2007) 790-799
4. Jones B. The case for particle therapy. Br J Radiol 79 (2006) 24-31
5. Jones B., Dale R.G., Green S.J., Kirkby K., and Peach K. Particle radiotherapy in the UK. Clin Oncol 20 (2008) 67-68
6. Lodge M., Pijls-Johannesma M., Stirk, et al. A systemic literature review of the clinical and cost effectiveness of hadron therapy in cancer. Radiother Oncol 83 (2007) 110-122
7. Brada M., Pijls-Johannesma M., and De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 25 (2007) 965-980
8. Olsen D.R., Bruland O.S., Frykholm G., and Norderhaug I.N. Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol 83 (2007) 123-132
9. Goitein M., and Cox J.D. Should randomized clinical trials (RCT) be required for proton radiotherapy?. J Clin Oncol 26 (2007) 175-176
10. Glimelius B., and Montelius A. Do we need the randomised trials and can we do without them?. Radiother Oncol 83 (2007) 105-109
11. Tsujii H., Mizoe J., Kamada T., et al. Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 48 Suppl (2007) A1-A13
12. Schultz-Ertner D., and Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 25 (2007) 953-964
13. Mole R.H. Late effects of radiation: carcinogenesis (1973), British Council, London 78-83
14. Pollack A. Hospitals look to nuclear tool to fight cancer. http://www.nytimes.com/2007/12/26/business/26proton.html?hp
15. Kosak K.R., Smith B.L., Adams J., et al. Accelerated partial breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 66 (2006) 691-698
16. Bush D.A., Slater J.D., Garberoglio C., Yuh G., Hocko J.M., and Slater J.M. A technique of partial breast irradiation utilizing proton beam radiotherapy with good skin sparing in comparison with conformal x-ray therapy. Cancer J 13 (2007) 114-118
17. MacDonald S.M., and Taghian A.G. Is it time to use protons for breast cancer?. Cancer J 13 (2007) 84-86
18. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
19. Taylor C.W., Nisbet A., McGale P., and Darby S.C. Cardiac exposures in breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 1484-1495
20. Taylor C.W., McGale P., and Darby S.C. Cardiac risks of breast cancer radiotherapy: a contemporary view. Clin Oncol 18 (2006) 236-246
21. Jones B., and Akine Y. Dose distribution to the mediastinum and heart. Br J Radiol 79 (2006) 448
22. Koyama S., and Tsujii H. Proton beam therapy with high dose irradiation for superficial and advanced esophageal carcinomas. Clin Cancer Res 9 (2003) 3571-3577
23. Sugahara S., Tokuuye K., Okumara T., et al. Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 61 (2005) 76-84
24. Hata M., Tokuuye K., Suguhara S., et al. Hypofractionated high dose proton beam therapy for stage I non small cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys 68 (2007) 786-793
25. Jones B., and Burnett N.G. The future for radiotherapy: protons and ions hold much promise. Br Med J 330 (2005) 979-980
26. Hata M., Miynaga N., Tokuuye K., et al. Proton beam therapy for invasive bladder cancer: a prospective study of bladder preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 1371-1379
27. Surma-aho O., Niemela M., Vilkki J., et al. Adverse long-term effects of brain radiotherapy in adult low grade glioma patients. Neurology 56 (2001) 1285-1290
28. Fitzek M.M., Thornton A.F., Rabinov J.D., et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 91 (1999) 251-260
29. Stupp R., Mason W.P., van den Bent M.J., et al., European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-989
30. Mizoe J.E., Tsujii H., Hasegawa A., et al. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy and carbon in radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 390-396
31. Jones B. Auditory toxicity after parotid irradiation. Clin Oncol 19 (2007) 557
32. Dorresteijn L.D.A., Kappelle A.C., Boogerd W., et al. Increased risk of ischaemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 24 (2006) 3693-3704
33. Haynes J.C., Machtay M., Weber R.S., et al. Relative risk of stroke in head and neck cancer patients treated with external radiation. Laryngoscope 112 (2002) 1883-1887
34. Tokuuye K., Akine Y., Kagei K., et al. Proton therapy for head and neck malignancies at Tsukuba 180, 246. Strahlenther Onkol 180 (2004) 96-101
35. Kato S., Ohno T., Tsujii H., et al. Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 65 (2006) 388-397
36. Bjork-Eriksson T., Bjelkengren G., and Glimelius B. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma. Acta Oncol 44 (2005) 913-917
37. Jones B., and Dale R.G. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials. Int J Radiat Oncol Biol Phys 69 (2007) 221-229
38. Jones B., and Errington R.D. Commentary: proton beam radiotherapy. Br J Radiol 73 (2000) 802-805
39. Hall E.J. The impact of protons on the incidence of second malignancies in radiotherapy. Technol Cancer Res Treat 6 4 Suppl (2007) 31-34